Diabetes, Obesity & Metabolism
Nephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney Disease
Experiments in miceInterventions
10 weeks
The paper
Gubra (Denmark); Boehringer Ingelheim (Germany)
Diabetes, Obesity & Metabolism, 1 Oct 2026


